LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Open Letter to Member States on the EU Court Ruling on Mutagenesis

    09/05/2019
    POSITION PAPER

    Open Letter to Member States on the EU Court Ruling on Mutagenesis

    09 May 2019

    Dear Madam, dear Sir,

    We, the undersigned European organisations, are writing to reiterate our concern about the European Court of Justice ruling on case C-528/16 (25 July 2018), by which the Court interpreted the provisions of the EU GMO Directive 2001/18 in such a way that products resulting from innovative, targeted mutagenesis methods are regulated under the provisions of the GMO-Directive.

    The introduction of targeted genetic variation in crops and other organisms can help to achieve important sustainable development goals and to contribute to a cleaner environment, to healthy diets, and the protection of biodiversity. It can also contribute to making crops more resilient and better withstand climate change.

    The costly and lengthy EU approval process for the products resulting from targeted mutagenesis, combined with potential national cultivation opt-outs under Directive 2001/18, will effectively deprive European farmers & consumers from the benefits of these products. Furthermore, the ruling is hindering the delivery to the market of innovative bio-based products and sustainable industrial, agricultural and healthcare solutions that involve gene-edited microorganisms. Some of the EUs most innovative sectors will effectively be cut off from scientific progress and be put at a competitive disadvantage compared to a rapidly growing group of countries with more enabling regulations.

    The ruling is also difficult to implement and virtually impossible to enforce, given that many gene-edited products may be indistinguishable from products changed by natural processes or with conventional breeding techniques, as reconfirmed by the report of the Joint research Centre “Detection of food and feed plant products obtained by new mutagenesis techniques”, published on 26 March 2019.

    The report highlights two aspects that are of major importance:
    1) “For non-unique DNA alterations affecting one or a few DNA base pairs, an applicant may not be able to develop an event-specific method.”
    2) “Plant products obtained by genome editing may enter the market undetected. Moreover, if a suspicious product with an unknown or non-unique DNA alteration would be detected on the EU market, it would be difficult or even impossible to provide court-proof evidence that the modified sequence originated from genome editing.“

    We are in full agreement with scientists, stakeholders and EU trade partners, that it has become urgent for the EU to adapt its legislation to reflect and welcome technical progress and align it with legislation in other parts of the world. We are committed to engaging with policy makers, stakeholders and all interested parties to work for a constructive, targeted change. Our goal is to obtain practical and science-based rules for products resulting from the latest mutagenesis methods that foster public confidence and trust. This would unlock great potential for a high-performing, innovative and diversified European bio-based solutions in sectors such as plant and animal breeding, agriculture, animal feed, food, healthcare and energy thereby contributing to Europe’s resilience to climate change, and to benefits for consumers, patients and the environment.

    Products should not be subject to Directive 2001/18 requirements and related regulations if they could also have been obtained through conventional methods or result from spontaneous processes in nature. We wish to emphasize that this position is also increasingly adopted as a principal regulatory approach in a growing number of countries around the world. It should also create legal certainty for EU operators by avoiding that Member States adopt individual national rules for products resulting from conventional, random mutagenesis. It will furthermore prevent that two otherwise indistinguishable products or organisms are regulated in two different ways, which would open the door to unfair competition with imports from non-EU countries.

    We therefore call upon member states and the EU Commission to initiate a legislative change that provides innovation-friendly rules.

    Yours sincerely,

    Céline Duroc, Director General | MAIZ'EUROP' for the Platform Agriculture and Progress
    Patrick Fox, Secretary General | Association of Manufacturers and Formulators of Enzyme Products
    Dirk Carrez, Executive Director | Bio-based Industries Consortium
    Marc Vermeulen, Executive Director Specialty Chemicals | The European Chemical Industry Council
    Marie-Christine Ribera, Director General | European Association of Sugar Manufacturers
    Jérôme Bandry, Secretary General | CEMA - European Agricultural Machinery
    Elisabeth Lacoste, Director | C.I.B.E. International Confederation of European Beet Growers
    Iliana Axiotiades, Secretary General | European Association of Cereals, Rice, Feedstuffs, Oil Seeds, Olive Oil, Oils and Fats and Agrosupply Trade
    Marc Casier, President | Confederation of European Yeast Producers
    Ana Granados Chapatte, Director | European Forum of Farm Animal Breeders
    Jean-Philippe Azoulay, Director General | European Crop Protection Association
    Bernard Valluis, President | European Flour Milling Association
    Patrick FOX, Secretary General | EFFCA - European Food and Feed Cultures Association
    Thierry de l'ESCAILLE, Secretary General - CEO | European Landowners' Organization
    Raquel Izquierdo, Secretary General | European Potato Trade Association
    Susanne Meyer, Secretary General | EUVEPRO - European Vegetable Protein Association
    Garlich von Essen, Secretary General | ESA - European Seed Association
    Joanna Dupont-Inglis, Secretary General |EuropaBio – The European Association for Bioindustries
    Aleksandra Malyska, Executive Manager | European Technology Platform Plants for the Future
    Nick Major, President | European Feed Manufacturers' Federation
    Joerg Seifert, Secretary General | FEFANA - EU Association of Specialty Feed Ingredients and their Mixtures
    Ernesto Morgado, President | Federation of European Rice Millers
    Nathalie Lecocq, Director General | FEDIOL - EU Vegetable Oil and Protein Meal Industry Association
    Mella Frewen, Director General |FoodDrinkEurope
    Jamie Fortescue, Managing Director | Starch Europe
    Sylvie Mamias, Secretary General | UNION FLEURS


    Download the file below to read the full letter.

    Open Letter to Member States on the EU Court Ruling on Mutagenesis


    Download
    2019_05_G_PP_ESA_19.0299-Letter-to-Member-States-at-ScopaffsDownload
    Share
    Communications Team
    Communications Team

    Related posts

    25/06/2026

    EuropaBio’s startups and SME feedback on the EU Inc. proposal


    Read more
    18/06/2026

    EuropaBio 2026 AGM Appoints New Board Members and Expands Membership


    Read more
    16/06/2026

    EFIB 2026 Den Haag Statement


    Read more

    Important links

    • The European CRO Federation (EUCROF) joins EuropaBio: Advancing clinical research excellence in Europe
    • EuropaBio’s startups and SME feedback on the EU Inc. proposal

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.